These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 33789754)

  • 1. Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture.
    Iskandar K; Molinier L; Hallit S; Sartelli M; Hardcastle TC; Haque M; Lugova H; Dhingra S; Sharma P; Islam S; Mohammed I; Naina Mohamed I; Hanna PA; Hajj SE; Jamaluddin NAH; Salameh P; Roques C
    Antimicrob Resist Infect Control; 2021 Mar; 10(1):63. PubMed ID: 33789754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries.
    Gandra S; Alvarez-Uria G; Turner P; Joshi J; Limmathurotsakul D; van Doorn HR
    Clin Microbiol Rev; 2020 Sep; 33(3):. PubMed ID: 32522747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance for antimicrobial drug resistance in under-resourced countries.
    Vernet G; Mary C; Altmann DM; Doumbo O; Morpeth S; Bhutta ZA; Klugman KP
    Emerg Infect Dis; 2014 Mar; 20(3):434-41. PubMed ID: 24564906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the factors that contribute to the successful implementation of antimicrobial resistance interventions: a comparison of high-income and low-middle-income countries.
    Graells T; Lambraki IA; Cousins M; Léger A; Henriksson PJG; Troell M; Carson CA; Parmley EJ; Majowicz SE; Wernli D; Jørgensen PS
    Front Public Health; 2023; 11():1230848. PubMed ID: 37900049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Setting up laboratory-based antimicrobial resistance surveillance in low- and middle-income countries: lessons learned from Georgia.
    Malania L; Wagenaar I; Karatuna O; Tambic Andrasevic A; Tsereteli D; Baidauri M; Imnadze P; Nahrgang S; Ruesen C
    Clin Microbiol Infect; 2021 Oct; 27(10):1409-1413. PubMed ID: 34044149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closing the GAP in Antimicrobial Resistance Policy in Benin and Burkina Faso.
    Sariola S; Butcher A; Cañada JA; Aïkpé M; Compaore A
    mSystems; 2022 Aug; 7(4):e0015022. PubMed ID: 35894597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing antimicrobial resistance in low and middle-income countries: overcoming challenges and implementing effective strategies.
    Rony MKK; Sharmi PD; Alamgir HM
    Environ Sci Pollut Res Int; 2023 Sep; 30(45):101896-101902. PubMed ID: 37610548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries.
    Lim C; Ashley EA; Hamers RL; Turner P; Kesteman T; Akech S; Corso A; Mayxay M; Okeke IN; Limmathurotsakul D; van Doorn HR
    Clin Microbiol Infect; 2021 Oct; 27(10):1391-1399. PubMed ID: 34111583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis.
    Alsan M; Schoemaker L; Eggleston K; Kammili N; Kolli P; Bhattacharya J
    Lancet Infect Dis; 2015 Oct; 15(10):1203-1210. PubMed ID: 26164481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying and addressing challenges to antimicrobial use surveillance in the human health sector in low- and middle-income countries: experiences and lessons learned from Tanzania and Uganda.
    Kiggundu R; Lusaya E; Seni J; Waswa JP; Kakooza F; Tjipura D; Kikule K; Muiva C; Joshi MP; Stergachis A; Kitutu FE; Konduri N
    Antimicrob Resist Infect Control; 2023 Feb; 12(1):9. PubMed ID: 36759872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance in countries with limited resources: unique challenges and limited alternatives.
    Sirinavin S; Dowell SF
    Semin Pediatr Infect Dis; 2004 Apr; 15(2):94-8. PubMed ID: 15185192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries.
    Alwan A; Maclean DR; Riley LM; d'Espaignet ET; Mathers CD; Stevens GA; Bettcher D
    Lancet; 2010 Nov; 376(9755):1861-8. PubMed ID: 21074258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Policy entrepreneurs are integral in efforts to curb antimicrobial resistance in low and middle income countries.
    Otaigbe II
    Front Public Health; 2024; 12():1292660. PubMed ID: 38532974
    [No Abstract]   [Full Text] [Related]  

  • 14. Zoonotic sources and the spread of antimicrobial resistance from the perspective of low and middle-income countries.
    Olaru ID; Walther B; Schaumburg F
    Infect Dis Poverty; 2023 Jun; 12(1):59. PubMed ID: 37316938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans.
    Munkholm L; Rubin O
    Global Health; 2020 Nov; 16(1):109. PubMed ID: 33176810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance in low- and middle-income countries: current status and future directions.
    Sulis G; Sayood S; Gandra S
    Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries.
    Harant A
    Antimicrob Resist Infect Control; 2022 Jan; 11(1):15. PubMed ID: 35073967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of electronic surveillance of infectious diseases with emphasis on antimicrobial resistance surveillance in resource-limited settings.
    Rattanaumpawan P; Boonyasiri A; Vong S; Thamlikitkul V
    Am J Infect Control; 2018 Feb; 46(2):139-146. PubMed ID: 29029814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance in developing countries. Part I: recent trends and current status.
    Okeke IN; Laxminarayan R; Bhutta ZA; Duse AG; Jenkins P; O'Brien TF; Pablos-Mendez A; Klugman KP
    Lancet Infect Dis; 2005 Aug; 5(8):481-93. PubMed ID: 16048717
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.